Trimedyne, Inc. reported financial results for the first quarter ended December 31, 2012. Revenues for the quarter ended December 31, 2012, were $1,475,000, a 6% increase from revenues of $1,390,000 for the same quarter of the prior year. The company had a net loss of $144,000 or $0.01 per share for the current quarter, compared to a loss of $285,000 or $0.02 per share for the same quarter of the prior year.
1st Jan change | Capi. | |
---|---|---|
+10.03% | 22TCr | |
+13.59% | 19TCr | |
+20.01% | 14TCr | |
+30.83% | 11TCr | |
+2.05% | 6.5TCr | |
+15.38% | 5.3TCr | |
+3.96% | 5.04TCr | |
+8.37% | 4.42TCr | |
+3.27% | 3.64TCr |